Updated Jul 16, 2026
Clark David Michael has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.15M.
David Michael Clark is the Chief People Officer at Amicus Therapeutics, Inc., a biotechnology company focused on developing medicines for rare diseases. He has been involved in multiple SEC filings related to his role within the company.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-27 | FOLD | AMICUS THERAPEUTICS, INC. | D — Derivative transaction | 221.8K | $14.50 | $3.22M |
| 2026-01-07 | FOLD | AMICUS THERAPEUTICS, INC. | F — Tax withholding / forfeiture | 18.5K | $14.27 | $264K |
| 2026-01-07 | FOLD | AMICUS THERAPEUTICS, INC. | F — Tax withholding / forfeiture | 5.4K | $14.27 | $77K |
| 2025-12-23 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 25.6K | $14.17 | $363K |
| 2025-12-17 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 25.6K | $11.00 | $282K |
| 2025-11-27 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale [10b5-1] | 25.6K | $10.10 | $259K |
| 2025-11-05 | FOLD | AMICUS THERAPEUTICS, INC. | S — Open-market sale | 25.6K | $9.51 | $244K |
David Michael Clark is the Chief People Officer at Amicus Therapeutics, Inc., a biotechnology company focused on developing medicines for rare diseases. He has been involved in multiple SEC filings related to his role within the company.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($1.15M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Clark David Michael profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.